DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
AMP-224
1
Unknown
Investigational
Unknown
Unknown
Colorectal Neoplasms; Neoplasms
Unknown
AMP-224
×
Maximum Phase:
1
First Approval:
None
UNII:
SKF3JJJ5QA
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RGB-286638
1
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms
Cyclin-dependent kinase 1 inhibitor
RGB-286638
×
Maximum Phase:
1
First Approval:
None
UNII:
1GAJ98SC2X
Molecule Type:
Small molecule
Molecular Formula:
C29H35N7O4
Molecular Weight:
545.64
AlogP:
2.42
PSA:
115.06
HBD:
3.0
HBA:
#RotB:
8.0
Source:
ATU027
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ATU027
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AGN-201904
1
Small molecule
Investigational
Unknown
Unknown
Peptic Ulcer
Unknown
AGN-201904
×
Maximum Phase:
1
First Approval:
None
UNII:
G0835O03ZM
Molecule Type:
Small molecule
Molecular Formula:
C25H25N3O8S2
Molecular Weight:
559.62
AlogP:
3.07
PSA:
146.91
HBD:
1.0
HBA:
#RotB:
10.0
Source:
FLUOCINOLONE
1
Small molecule
Investigational
Unknown
Unknown
Wet Macular Degeneration
Unknown
FLUOCINOLONE
×
Maximum Phase:
1
First Approval:
None
UNII:
CT1IX58L9S
Molecule Type:
Small molecule
Molecular Formula:
C21H26F2O6
Molecular Weight:
412.43
AlogP:
0.57
PSA:
115.06
HBD:
4.0
HBA:
#RotB:
2.0
Source:
DSTP3086S
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
DSTP3086S
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RACLOPRIDE C 11
1
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders; Opioid-Related Disorders; Depressive Disorder
Unknown
RACLOPRIDE C 11
×
Maximum Phase:
1
First Approval:
None
UNII:
GE077RPG04
Molecule Type:
Small molecule
Molecular Formula:
C15H20Cl2N2O3
Molecular Weight:
346.24
AlogP:
2.92
PSA:
61.8
HBD:
2.0
HBA:
#RotB:
5.0
Source:
GS-6620
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic
Unknown
GS-6620
×
Maximum Phase:
1
First Approval:
None
UNII:
WD5DUG7X38
Molecule Type:
Small molecule
Molecular Formula:
C29H37N6O9P
Molecular Weight:
644.62
AlogP:
2.88
PSA:
209.62
HBD:
3.0
HBA:
#RotB:
12.0
Source:
SALCAPROZIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SALCAPROZIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
X88E147FCU
Molecule Type:
Small molecule
Molecular Formula:
C15H21NO4
Molecular Weight:
279.34
AlogP:
2.55
PSA:
86.63
HBD:
3.0
HBA:
#RotB:
9.0
Source:
TRV-120027
1
Protein
Investigational
Unknown
Unknown
Heart Failure; Severe Acute Respiratory Syndrome
Unknown
TRV-120027
×
Maximum Phase:
1
First Approval:
None
UNII:
J1J4P3PQZD
Molecule Type:
Protein
Molecular Formula:
C43H67N13O10
Molecular Weight:
926.09
AlogP:
-1.91
PSA:
355.05
HBD:
13.0
HBA:
#RotB:
26.0
Source:
BUDIGALIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; HIV Infections; Neoplasms; Ovarian Neoplasms; Small Cell Lung Carcinoma
Programmed cell death protein 1 inhibitor
BUDIGALIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
6VDO4TY3OO
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASP-4058
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ASP-4058
×
Maximum Phase:
1
First Approval:
None
UNII:
01J7526K2Q
Molecule Type:
Small molecule
Molecular Formula:
C19H12F6N4O2
Molecular Weight:
442.32
AlogP:
5.63
PSA:
76.83
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MUSCIMOL
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy; Parkinson Disease
Unknown
MUSCIMOL
×
Maximum Phase:
1
First Approval:
None
UNII:
D5M179TY2E
Molecule Type:
Small molecule
Molecular Formula:
C4H6N2O2
Molecular Weight:
114.1
AlogP:
-0.16
PSA:
72.28
HBD:
2.0
HBA:
#RotB:
1.0
Source:
TIBULIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Sjogren's Syndrome
Interleukin 17A inhibitor
TIBULIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
42HQ15W1ZF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FBT-A05
1
Antibody
Investigational
Unknown
Unknown
Unknown
B-lymphocyte antigen CD20 cross-linking agent
FBT-A05
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK2879552
1
Small molecule
Investigational
Unknown
Unknown
Leukemia; Myelodysplastic Syndromes; Small Cell Lung Carcinoma
Unknown
GSK2879552
×
Maximum Phase:
1
First Approval:
None
UNII:
GT77Z6Y09Z
Molecule Type:
Small molecule
Molecular Formula:
C23H28N2O2
Molecular Weight:
364.49
AlogP:
3.74
PSA:
52.57
HBD:
2.0
HBA:
#RotB:
7.0
Source:
RG-7603
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Serine/threonine-protein kinase mTOR inhibitor
RG-7603
×
Maximum Phase:
1
First Approval:
None
UNII:
579255I6O9
Molecule Type:
Small molecule
Molecular Formula:
C24H32N6O3
Molecular Weight:
452.56
AlogP:
2.27
PSA:
91.85
HBD:
2.0
HBA:
#RotB:
5.0
Source:
NONA-L-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NONA-L-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TTC-352
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
TTC-352
×
Maximum Phase:
1
First Approval:
None
UNII:
65ILH3Y0MI
Molecule Type:
Small molecule
Molecular Formula:
C20H13FO3S
Molecular Weight:
352.39
AlogP:
5.91
PSA:
49.69
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TEMANOGREL
1
Small molecule
Investigational
Unknown
Unknown
Acute Coronary Syndrome
Serotonin 2a (5-HT2a) receptor inverse agonist
TEMANOGREL
×
Maximum Phase:
1
First Approval:
None
UNII:
F42Z27575A
Molecule Type:
Small molecule
Molecular Formula:
C24H28N4O4
Molecular Weight:
436.51
AlogP:
3.06
PSA:
77.85
HBD:
1.0
HBA:
#RotB:
8.0
Source:
GSK-625433
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GSK-625433
×
Maximum Phase:
1
First Approval:
None
UNII:
2YAD6KT0NT
Molecule Type:
Small molecule
Molecular Formula:
C26H32N4O5S
Molecular Weight:
512.63
AlogP:
4.02
PSA:
106.78
HBD:
1.0
HBA:
#RotB:
8.0
Source:
FANAPANEL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FANAPANEL
×
Maximum Phase:
1
First Approval:
None
UNII:
E3AP71EM0O
Molecule Type:
Small molecule
Molecular Formula:
C14H15F3N3O6P
Molecular Weight:
409.26
AlogP:
0.68
PSA:
124.86
HBD:
3.0
HBA:
#RotB:
3.0
Source:
APTO-253
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
APTO-253
×
Maximum Phase:
1
First Approval:
None
UNII:
WB59MRW00U
Molecule Type:
Small molecule
Molecular Formula:
C22H14FN5
Molecular Weight:
367.39
AlogP:
5.26
PSA:
70.25
HBD:
2.0
HBA:
#RotB:
1.0
Source:
MU-BC-1
1
Antibody
Investigational
Unknown
Unknown
Unknown
Fibronectin binding agent
MU-BC-1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALANOLIDE A
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
CALANOLIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
S5A9TQN46W
Molecule Type:
Small molecule
Molecular Formula:
C22H26O5
Molecular Weight:
370.45
AlogP:
4.38
PSA:
68.9
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ABCD
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ABCD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDOLE-3-CARBINOL
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Tobacco Use Disorder; Obesity
Unknown
INDOLE-3-CARBINOL
×
Maximum Phase:
1
First Approval:
None
UNII:
C11E72455F
Molecule Type:
Small molecule
Molecular Formula:
C9H9NO
Molecular Weight:
147.18
AlogP:
1.66
PSA:
36.02
HBD:
2.0
HBA:
#RotB:
1.0
Source:
GS-9901
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular
Unknown
GS-9901
×
Maximum Phase:
1
First Approval:
None
UNII:
U09Q76B8VK
Molecule Type:
Small molecule
Molecular Formula:
C22H17ClFN9O
Molecular Weight:
477.89
AlogP:
2.96
PSA:
161.42
HBD:
3.0
HBA:
#RotB:
5.0
Source:
ADG-106
1
Unknown
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Unknown
ADG-106
×
Maximum Phase:
1
First Approval:
None
UNII:
I4QM8E7Y2R
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GDC-0425
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GDC-0425
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-986115
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
BMS-986115
×
Maximum Phase:
1
First Approval:
None
UNII:
LSK1L593UU
Molecule Type:
Small molecule
Molecular Formula:
C26H25F7N4O3
Molecular Weight:
574.5
AlogP:
4.77
PSA:
113.65
HBD:
3.0
HBA:
#RotB:
9.0
Source:
CP-742,033
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CP-742,033
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIROCAFTOR
1
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
DIROCAFTOR
×
Maximum Phase:
1
First Approval:
None
UNII:
2G3T6M1AS9
Molecule Type:
Small molecule
Molecular Formula:
C22H28N2O3Si2
Molecular Weight:
424.65
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MLN-0415
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
MLN-0415
×
Maximum Phase:
1
First Approval:
None
UNII:
P6CWN9ULN1
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SD-0006
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
SD-0006
×
Maximum Phase:
1
First Approval:
None
UNII:
C57VF8YO91
Molecule Type:
Small molecule
Molecular Formula:
C20H20ClN5O2
Molecular Weight:
397.87
AlogP:
2.89
PSA:
95.0
HBD:
2.0
HBA:
#RotB:
4.0
Source:
1
2
…
115
116
117
118
119
120
121
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA